Navigation Links
MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
Date:11/19/2008

John T. Mayberry Decides to Step Down as Chairman

TORONTO, Nov. 19 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life-sciences markets, today announced the appointment of James S.A. MacDonald as Chairman of the Company's Board of Directors.

Mr. MacDonald, whose appointment is effective immediately, has been a member of the MDS Board since July 2005. John T. Mayberry, who joined the MDS Board in January 2004, and was appointed Chairman in October of that year, has resigned from the Board, citing other business obligations for his decision to step down. The Board has accepted his resignation.

"Jim MacDonald's deep financial expertise, experience in capital markets and in-depth knowledge of our businesses makes him the ideal choice to lead our Board at this stage in our evolution," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc. "I would like to thank John Mayberry for the tremendous contribution he has made to MDS. During his tenure as Chairman, John was instrumental in overseeing the transformation of MDS to a pure-play, global life-sciences company, and championed continuous improvement in corporate governance."

"As an MDS shareholder and member of the Company's Board for the past three-and-a-half years, I've had the opportunity to work closely with MDS's leadership team to focus on driving growth, improving operating performance and shaping the business portfolio," said Mr. MacDonald. "As the new Chairman, I will continue the Board's efforts to create long-term value for shareholders."

Mr. MacDonald, who is a member of the Board's Audit Committee, is Chairman and Managing Partner of Enterprise Capital Management Inc. Prior to 1997, Mr. MacDonald was Deputy Chairman of Scotia McLeod Inc. He is also a director of Cinram International Income Fund, Cymbria Corporation, Manitoba Telecom Services Inc. and Superior Plus Inc., and non executive Chairman of Cormark Securities Inc.

Mr. Mayberry retired as Chairman and CEO of Dofasco Inc., a leading producer of primary steel and finished steel products, in 2003. Leadership and commitment to community are trademarks of Mr. Mayberry's life, for which he received the Order of Canada in 2006.

About MDS Inc.

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life-sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 5,500 highly skilled people in 29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.


'/>"/>
SOURCE MDS Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. USA-ONE Interactive Announces Document Management Solutions That Meet the Needs of Individual Industries
2. Barr Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges
3. Acumen Fund Announces New Investments In Pakistan To Build Scalable Business That Serve The Poor
4. QC Sciences™ Announces Innovative Solution to Reduce Laboratory Costs : The NuView System™ For Non-Gynecologic Cytology Affords Substantial Savings
5. Capella University Announces $50,000 in Scholarships to Graduate Students in Mental Health Services : Ten students are awarded scholarships at online university
6. Message Archiving Leader Privacy Networks Announces Free Anti-Spam Software to Businesses and Organizations
7. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
8. Pregis Announces Third Quarter 2008 Financial Results
9. eDiets.com(R) Announces Q3 2008 Results
10. Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
11. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... ... Periodontist Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative ... by Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a ...
(Date:1/20/2017)... ... ... Source Vitál Apothecary, a skin and body care company dedicated to creating ... a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition Conference in ... nutritional, sports and health industries a chance to meet in private sessions with some ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has ... 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and have ... workout. , After a successful launch in Sweden last year, the next generation ...
(Date:1/20/2017)... ... 2017 , ... “I Forgive You”: a fine examination of how God handles sin, including ... of published author, Stephen Miller, who, for over ten long years has been waiting to ... in Trinidad and Tobago, he has been serving the Lord for over twenty years, and ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
(Date:1/19/2017)... 2017 Report Details ... Alzheimer,s Disease Therapeutics ... – our new study reveals trends, R&D progress, and ... affecting the Alzheimer,s disease therapeutics and diagnostics market. Our ... questions: - How is the Alzheimer,s disease therapeutics and ...
(Date:1/19/2017)... 19, 2017 According to a study conducted ... set to witness a CAGR of 6.5% during the forecast period ... will continue to be the leading market for cryotherapy globally during ... ... on ensuring affordable and adequate supply of gas in order to ...
Breaking Medicine Technology: